Abstract
A model for estimating the number of COVID-19 infected persons (infecteds) is proposed based on the exponential function law of the SIR model. This model is composed of several equations expressing the number of infecteds, considering the onset after an incubation period, infectivity, wavy infection persistence with repeated infection spread and convergence with insufficient quarantine. This model is applied to the infection in Japan, which is currently suffering from the 5th wave, and the initial number of infecteds and various related parameters are calculated by curve fitting of the cumulative number of infecteds to the total cases in the database. As a minimum boundary of the number of infecteds for the infection continuation up to the 5th wave, the initial number of infecteds at the outbreak of infection is more than an order of magnitude higher than the actual initial cases. A convergence ratio (cumulative number of infecteds / total cases) at the end of the first wave is obtained as 1.5. The quarantine rate and social distancing ratio based on the SIQR model are evaluated, and the social distancing ratio increases sharply just after the government’s declaration of emergency. The quarantine rate closely equals the positive rate by PCR tests, meaning that the number of infecteds, which had been unknown, is on the order of almost the same as the number of tests.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
N/A
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced are available online at Our World in Data COVID-19 dataset
